The weight loss drug market, projected to hit $100 billion by the decade's end, is undergoing significant innovation. Amidst dominant players like Novo Nordisk and Eli Lilly, Amgen is emerging with MariTide, a potentially game-changing drug set to disrupt the industry. MariTide's extended-release formula promises reduced dosing frequency and sustained weight loss,...
Amgen Inc.'s shares ( NASDAQ:AMGN ) rose by 15.9% when the market opened on Friday, marking its biggest intraday rise since July 2009. The company has emerged as a potential competitor to Eli Lilly & Co. and Novo Nordisk A/S, which currently dominate the weight-loss market. Demand for anti-obesity drugs like Zepbound and Wegovy is so strong that Intelligence's...
Reasons for bullish bias:
- Price bounced from support
- Weekly bullish candle closing at support
- 0.5 fib retracement
Entry Level (CMP): 278.40
Stop Loss Level: 264.03
Take Profit Level 1: 292.77
Take Profit Level 2: 307.14
Take Profit Level 3: Open
Reasons for bullish bias:
- Price bounced from strong support along with 0.382 fib retracement
- Price respected trendline
- Strong bullish candles
Entry Level(CMP): 291.29
Stop Loss Level: 279.64
Take Profit Level 1: 302.94
Take Profit Level 2: Open
The Minichart Trendline indicator has determined that the share price of Amgen Inc. has just broken its downtrend and is likely to recover from here.
This indicator developed by Minichart can detect stocks that change their trend, either from an uptrend to a downtrend or vice versa. It is plotted automatically.
First of all, Amgen Inc. stock price reached a...
After a major uptrend the stock almost starts to finish its correction wave and showed some postivity , we can start buy after the price to settle above its last peak at 298
TP 1 : 304
TP 2 :309
TP 3 : 314
TP 4 : 320
SL > 288
GOOD LUCK
If you haven`t sold AMGN ahead of the HZNP buyout:
Then analyzing the options chain and the chart patterns of AMGN Amgen prior to the earnings report this week,
I would consider purchasing the $322.5 strike price Calls with
an expiration date of 2024-2-9,
for a premium of approximately $6.60.
If these options prove to be profitable prior to the earnings...
## Amgen Poised for Continued Upside
Amgen Inc. (AMGN) appears poised for continued upside based on technical indicators. The current price of $324.56 is above the 50-day and 200-day simple moving averages, indicating an upward trend.
Key technical indicators also suggest further upside:
- Relative Strength Index (RSI) of 66 indicates AMGN is not overbought...
🌟 Lumakras Breakthrough:
Amgen (AMGN) pioneers cancer treatment with Lumakras, the first medication targeting a mutation found in approximately 13% of lung cancer patients.
💰 Strategic Acquisition:
Amgen acquires Horizon Therapeutics for a substantial $28 billion in cash.
Incorporates Tepezza, an FDA-approved medicine for thyroid eye disease, into Amgen's product...
Hi traders,
let's take a look at the AMGN chart.
Price is retesting the previous all time high, which we expect to act as the resistance therefore, before the price continues the uptrend we are expecting pullback.
RSI has entered into overbought conditions.
Entry. stop loss and 2 targets for the short position are shown on the chart.
The idea is purely...
Amgen has been stuck at its current price area for almost 3-1/2 years, but now some traders may expect its longer-term uptrend to resume.
The first pattern on today’s chart is the $255-260 price zone. It roughly matches peaks in the summer of 2020, the spring of 2021 and the spring of 2022. AMGN ripped through it late last year, pulled back and stalled at the...
If you haven`t sold AMGN on the HZNP deal:
Then analyzing the options chain and the chart patterns of AMGN Amgen prior to the earnings report this week,
I would consider purchasing the 262.5usd strike price Puts with
an expiration date of 2023-11-17,
for a premium of approximately $8.15.
If these options prove to be profitable prior to the earnings release, I...
Amgen / AMGN is having an incredible price jump on a 1day MACD Buy Cross.
Inside this long term Channel Up pattern, the stock isn't unfamiliar at all with such explosive legs upwards as the same move happened in August 4th/7th/8th.
It is a clear wedge consolidation into aggressive expansion pattern. All supported by the 1day MA50.
It is not too late to buy and...
Amgen Inc (AMGN) broke above the quick Bull Flag pattern and is targeting the top of the Channel Down pattern at 277.00. Based on the 1D MACD, this is a symmetrical bullish sequence as the one that peaked in early November. That will be a major test for the uptrend as the longer the price stays high, the easier it will form a 1D Golden Cross, the first since...
